The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Controlled Neutrophil Production Could Improve Immunometabolism

Controlled Neutrophil Production Could Improve Immunometabolism

February 6, 2015 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A new study of cellular biology in mice unexpectedly turned up a potential pathway to help patients with rheumatoid arthritis (RA).

You Might Also Like
  • Neutrophil Extracellular Traps & Their Role in Autoimmunity
  • New Methodology to Improve Cartilage Repair
  • EULAR 2014: Biosimilar Drug Production Raises Concerns
Also By This Author
  • Do Women Receive Worse Gout Treatment Than Men?

The study, “Peroxisomal Lipid Synthesis Regulates Inflammation by Sustaining Neutrophil Membrane Phospholipid Composition and Viability,” published in January’s Cell Metabolism, found that by controlling neutrophils—a well-known marker of inflammation—researchers may be able to use a previously unrecognized pathway to improve immunometabolism.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“This is a proof-of-principle experiment that stumbled on a completely unexpected way to control the production of neutrophils,” says Clay Semenkovich, MD, chief of the Division of Endocrinology, Metabolism and Lipid Research at Washington University in St. Louis. “You wouldn’t want someone’s neutrophils to go completely away, but you could do small-molecule screening for inhibition of the particular pathways targeted in our work and then titrate the amount that you give.

“In somebody who had very robust RA, you might be able to decrease the concentration of neutrophils in a joint. Or you could take a small molecule inhibitor and inject it into a damaged joint to decrease the ability of neutrophils to damage the synovial surface.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Semenkovich says researchers examined the bone marrow of dead mice and “serendipitously” found that when cells make fatty acids, they channel them to peroxisomes where, when they’re modified in a certain way, ether lipids are created. Interfering with that pathway could one day provide insights on screening and treatment for RA patients.

“Ether lipid signatures could be predictive of people who would have inflammatory processes. Lowering ether lipids could represent a potential strategy to decrease the inflammatory processes for people who already have the disease,” Dr. Semenkovich adds. “It is one more example of doing basic research and coming up with unexpected observations that have the potential to decrease suffering in people who have arthritis.”

Richard Quinn is a freelance writer in New Jersey.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

1. Lodhi IJ, Wei X, Yin L, et al. Peroxisomal lipid synthesis regulates inflammation by sustaining neutrophil membrane phospholipid composition and viability. Cell Metabolism. 2015 Jan;21(1):51–64.

Filed Under: Conditions Tagged With: ether lipids, neutrophil, Quinn

You Might Also Like:
  • Neutrophil Extracellular Traps & Their Role in Autoimmunity
  • New Methodology to Improve Cartilage Repair
  • EULAR 2014: Biosimilar Drug Production Raises Concerns
  • Decode the Crosstalk Between Bones, Brain, and Fat

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)